<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04883697</url>
  </required_header>
  <id_info>
    <org_study_id>RAI</org_study_id>
    <nct_id>NCT04883697</nct_id>
  </id_info>
  <brief_title>Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique</brief_title>
  <official_title>Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vienna Institute for Research in Ocular Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vienna Institute for Research in Ocular Surgery</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A retrospective review of medical charts of patients having undergone vitrectomy with ILM&#xD;
      Peeling and ILM flap technique for macular hole repair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A retrospective review of medical charts of patients having undergone vitrectomy with ILM&#xD;
      Peeling and ILM flap technique for macular hole repair. Pre- and postoperative OCT and visual&#xD;
      acuity in the time period up to 6 months after surgery are reviewed and possible risk factors&#xD;
      for failed macular hole closure or lower visual acuity outcome after surgery are assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Actual">May 1, 2021</completion_date>
  <primary_completion_date type="Actual">May 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>visual acuity</measure>
    <time_frame>change between visual acuity 2-6 months postoperative to baseline</time_frame>
    <description>best corrected distance visual acuity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>macular hole closure</measure>
    <time_frame>2-6 months postoperative</time_frame>
    <description>closure of the macular hole assesed with OCT</description>
  </primary_outcome>
  <enrollment type="Actual">71</enrollment>
  <condition>Macular Holes</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>vitrectomy with ILM peeling and ILM flap technique</intervention_name>
    <description>outcomes after vitrectomy with ILM peeling and ILM flap technique for macukar hole repair are assessed</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patieints have undergone vitrectomy with ILM peeling and ILM flap technique in the time&#xD;
        period form 1.1.2015 to 31.4.2020 for macular hole repair&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Vitrectomy with ILM peeling and ILM flap technique in the time period form 1.1.2015 to&#xD;
             31.4.2020&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>105 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Oliver Findl</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vienna Institute for Research in Ocular Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vienna Institute for Research in Ocular Surgery</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 1, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2021</study_first_posted>
  <last_update_submitted>May 6, 2021</last_update_submitted>
  <last_update_submitted_qc>May 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vienna Institute for Research in Ocular Surgery</investigator_affiliation>
    <investigator_full_name>Prim. Prof. Dr. Oliver Findl, MBA</investigator_full_name>
    <investigator_title>Prim., Prof., MBA</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

